Patient perspective on virtual prechemotherapy visits in gynecologic oncology
CONCLUSIONS: Most patients are highly satisfied with virtual visits and prefer virtual care to be included when undergoing chemotherapy. A hybrid model should be offered to gynecological cancer patients undergoing chemotherapy, with patient preference dictating the cadence of virtual visits.PMID:38694709 | PMC:PMC11061257 | DOI:10.1016/j.gore.2024.101397 (Source: Ann Oncol)
Source: Ann Oncol - May 2, 2024 Category: Cancer & Oncology Authors: Monica J Janke Bryan Aaron Hannah D McLaughlin Yang Liu Shitanshu Uppal Source Type: research
Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia
CONCLUSIONS: Nipple excision is effective management for nipple margins containing tumor. No intervention is required for nipple margins containing only atypia. Our results support broad eligibility for NSM with careful nipple margin assessment.PMID:38691238 | DOI:10.1245/s10434-024-15362-1 (Source: Ann Oncol)
Source: Ann Oncol - May 1, 2024 Category: Cancer & Oncology Authors: Julia N Shanno Abigail E Daly Kyle J Anderman Heidi S Santa Cruz Alexandra J Webster Robert M Pride Michelle C Specht Michele A Gadd Tawakalitu O Oseni Francys C Verdial Tolga Ozmen Rebecca Kwait Amy S Colwell Barbara L Smith Source Type: research
Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases
CONCLUSION: To our knowledge, this report is the first to investigate CNS-specific outcomes based on transcription factor subtypes in patients with SCLC. BM-free patients at diagnosis with A+/N- or A-/N+ subtypes had worse outcomes compared with those with transcriptional factor coexpression. Further investigation into the mechanisms and implications of SCLC subtyping on CNS-specific outcomes is warranted to ultimately guide personalized care.PMID:38691815 | DOI:10.1200/PO.23.00470 (Source: Ann Oncol)
Source: Ann Oncol - May 1, 2024 Category: Cancer & Oncology Authors: Kathryn R Tringale Anna Skakodub Jacklynn Egger Jordan Eichholz Yao Yu Daniel Gomez Andreas Rimner Bob Li Yoshiya Yamada Jessica Wilcox Nelson Moss Brandon S Imber Natasha Rekhtman Marina K Baine Charles M Rudin Luke R G Pike Source Type: research
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum
CONCLUSIONS: Patients with siNETs metastatic to both the liver and peritoneum have favorable outcomes after aggressive surgical cytoreduction, with the best outcomes observed after complete cytoreduction. Therefore, the presence of peritoneal metastases should not by itself preclude surgical cytoreduction in this population.PMID:38689169 | DOI:10.1245/s10434-024-15316-7 (Source: Ann Oncol)
Source: Ann Oncol - April 30, 2024 Category: Cancer & Oncology Authors: Hallbera Gudmundsdottir Alessandro Fogliati Travis E Grotz Cornelius A Thiels Susanne G Warner Rory L Smoot Mark J Truty Michael L Kendrick David M Nagorney Thorvardur R Halfdanarson Sean P Cleary Patrick Starlinger Source Type: research
ASO Author Reflections: Application of Robotic Technique for Treatment of Biliary Sclerosis from Hepatic Artery Infusion Pump Chemotherapy
Ann Surg Oncol. 2024 Apr 30. doi: 10.1245/s10434-024-15368-9. Online ahead of print.NO ABSTRACTPMID:38689170 | DOI:10.1245/s10434-024-15368-9 (Source: Ann Oncol)
Source: Ann Oncol - April 30, 2024 Category: Cancer & Oncology Authors: Maria Christodoulou Tara M Pattilachan Sharona Ross Emanuel Shapera Iswanto Sucandy Source Type: research
ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis
Ann Surg Oncol. 2024 Apr 30. doi: 10.1245/s10434-024-15339-0. Online ahead of print.NO ABSTRACTPMID:38689171 | DOI:10.1245/s10434-024-15339-0 (Source: Ann Oncol)
Source: Ann Oncol - April 30, 2024 Category: Cancer & Oncology Authors: Kavin Sugumar Henry Stitzel Victoria Wu David Bajor Sakti Chakrabarti Madison Conces Lauren Henke Melissa Lumish Amit Mahipal Amr Mohamed Jordan M Winter Jeffrey M Hardacre John B Ammori Jennifer E Selfridge Lee M Ocuin Source Type: research
Prognostic and Predictive Significance of Ki67 in Primary Non-metastatic or Recurrent Acral Melanoma: Evidence from a Multicenter Retrospective Study
CONCLUSIONS: A high Ki67 value was significantly associated with adverse pathological and prognostic features in both primary and recurrent AM cohorts. Ki67 should be routinely evaluated to guide risk stratification and prognostic prediction.PMID:38689172 | DOI:10.1245/s10434-024-15327-4 (Source: Ann Oncol)
Source: Ann Oncol - April 30, 2024 Category: Cancer & Oncology Authors: Chengcai Liang Dandan Li Yin Liang Yang Xie Naiyu Lin Huajie Guan Wanming Hu Yuanxiang Guan Yao Liang Source Type: research
Emergency Department Use in Adolescent and Young Adult Cancer Early Survivors from 2006 to 2020
Conclusion: ED utilization declined as time from diagnosis elapsed, but higher utilization was associated with social determinants of health and cancer types.PMID:38682323 | DOI:10.1089/jayao.2023.0174 (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Karen J Wernli Eric C Haupt Neetu Chawla Thearis Osuji Ernest Shen Andrew B Smitherman Mallory Casperson Anne C Kirchhoff Bradley J Zebrack Theresa H M Keegan Lawrence Kushi Christopher Baggett Heydon K Kaddas Kathryn J Ruddy Candice A M Sauder Theodore W Source Type: research
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer
CONCLUSIONS REPORTED BY THE RESEARCHERS?: The study showed that sacituzumab govitecan had significant anti-cancer activity. Though most participants who received sacituzumab govitecan experienced side effects, these did not usually stop participants from continuing sacituzumab govitecan. Doctors can help control these side effects using treatment guidelines, but these side effects can be serious. Clinical Trial Registration: NCT03547973 (ClinicalTrials.gov) (TROPHY-U-1).PMID:38682560 | DOI:10.2217/fon-2023-1030 (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Yohann Loriot Arash Rezazadeh Kalebasty Aude Fl échon Rohit K Jain Sumati Gupta Manojkumar Bupathi Philippe Beuzeboc Phillip Palmbos Arjun V Balar Christos E Kyriakopoulos Damien Pouessel Cora N Sternberg Julia Tonelli Mitch Sierecki Huafeng Zhou Petros Source Type: research
ASO Visual Abstract: Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer During Neoadjuvant Chemoradiation
Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15344-3. Online ahead of print.NO ABSTRACTPMID:38683303 | DOI:10.1245/s10434-024-15344-3 (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Xin Xiao Pin-Hao Fang Jian-Feng Zhou Xiao-Kun Li Qi-Xin Shang Yu-Shang Yang Si-Yuan Luan Long-Qi Chen Yong Yuan Source Type: research
The Role of Delirium on Short- and Long-Term Postoperative Outcomes Following Major Gastrointestinal Surgery for Cancer
CONCLUSIONS: Postoperative delirium occurred in one in 50 patients undergoing surgical resection of a digestive tract cancer. Delirium was linked to a reduced likelihood of achieving an optimal postoperative outcome, increased ICU utilization, higher expenditures, and a worse long-term prognosis. Initiatives to prevent delirium are vital to improve postoperative outcomes among cancer surgery patients.PMID:38683304 | DOI:10.1245/s10434-024-15358-x (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Erryk S Katayama Hunter Stecko Selamawit Woldesenbet Mujtaba Khalil Muhammad Musaab Munir Yutaka Endo Diamantis Tsilimigras Timothy M Pawlik Source Type: research
ASO Author Reflections: Do Patients with Ipsilateral Breast Tumor Recurrence Prefer Repeat Breast-Conserving Surgery or Mastectomy?
Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15363-0. Online ahead of print.NO ABSTRACTPMID:38683305 | DOI:10.1245/s10434-024-15363-0 (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Yukiko Seto Makoto Ishitobi Takahiro Nakayama Source Type: research
ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery
Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15295-9. Online ahead of print.NO ABSTRACTPMID:38683306 | DOI:10.1245/s10434-024-15295-9 (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Cary Kaufman Terry Sarantou Cory Donovan Ayfer Kamali Polat Peggy Thomas Bonnielyn Mack Source Type: research
ASO Author Reflections: Percutaneous Hepatic Perfusion: Past, Present, and Future
Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15364-z. Online ahead of print.NO ABSTRACTPMID:38683307 | DOI:10.1245/s10434-024-15364-z (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Jonathan S Zager Source Type: research
Emergency Department Use in Adolescent and Young Adult Cancer Early Survivors from 2006 to 2020
Conclusion: ED utilization declined as time from diagnosis elapsed, but higher utilization was associated with social determinants of health and cancer types.PMID:38682323 | DOI:10.1089/jayao.2023.0174 (Source: Ann Oncol)
Source: Ann Oncol - April 29, 2024 Category: Cancer & Oncology Authors: Karen J Wernli Eric C Haupt Neetu Chawla Thearis Osuji Ernest Shen Andrew B Smitherman Mallory Casperson Anne C Kirchhoff Bradley J Zebrack Theresa H M Keegan Lawrence Kushi Christopher Baggett Heydon K Kaddas Kathryn J Ruddy Candice A M Sauder Theodore W Source Type: research
